Chemical and Pharmaceutical Bulletin p. 1266 - 1269 (1993)
Update date:2022-09-26
Topics:
Itokawa
Kondo
Hitotsuyanagi
Nakamura
Morita
Takeya
Several aromatic ring substituent modified RA derivatives were prepared from RA-VII (I), RA-V (8) and RA-II (II), and evaluated for cytotoxicity against P388 leukemia and KB cells. In terms of IC50 values, the C(ζ) methoxyl group of Tyr-3 greatly influenced the activities, while the substituents at the C(ζ) position of Tyr-6 were less important. One of the derivatives, Tyr-6-C(ζ)-deoxyRA-V (9, P388, IC50, 0.0025μg/ml) was nearly as active as RA-VII (1, 0.0013 μg/ml), and also expressed promising anti- P388 in vivo activity (test/control = 171%, at 25 mg/kg).
View Morewebsite:http://www.synchemie.com/
Contact:+86-574-87642758
Address:Room 901, Yinyi Bund Building, 132 Renmin Road
Jewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
Guangxi Shanyun Biochemical Science and Technology Co., Ltd
Contact:+86-0772--6828887
Address:#2 Industrial Park of Luzhai County, Liuzhou, Guangxi, China
Taizhou volsen chemical Co., Ltd
website:http://www.volsenchem.com
Contact:+86-576-88869393
Address:Jiaojiang District, Taizhou, Zhejiang, China.
Huzhou City Linghu Xinwang Chemical Co.,Ltd.
Contact:86-572-3948695/3945236
Address:huzhou
Doi:10.1002/jhet.5570300411
(1993)Doi:10.1016/S0040-4039(00)60409-4
(1993)Doi:10.1055/s-1994-25460
(1994)Doi:10.1039/c3dt52655k
(2014)Doi:10.1016/j.molstruc.2013.11.026
(2014)Doi:10.1016/j.carres.2013.11.016
(2014)